Summary
- Current Price
- As of today, OTLK price is $0.98, down -6.06% on
- Current Price All-Time High
- OTLK price is currently -99.89% below its historical high of $878.40 set on
- Market Cap
- OTLK current market cap is $183M, up +114.38% over the past 365 days
- Revenue
- OTLK current annual revenue is $1.41M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for OTLK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Outlook Therapeutics, Inc. |
| Ticker | NASDAQ: OTLK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | outlooktherapeutics.com |
| Employees | 23 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.98 | ||
| Price, 1D Change | -6.06% | |
| $183M | ||
| - | ||
| - | ||
| 1.09 | ||
| $1M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.79 | ||
| EPS, 1Y Change | +55.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ONS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.79 | ||
| EPS Estimate | N/A | -$0.49 |
| EPS Est. Change | N/A | +72.50% |
| $1.41M | ||
| Revenue Estimate | N/A | $4.12M |
| Revenue Est. Change | N/A | +191.62% |
| $0.98 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +411.77% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.01 | -$4.06 | -1.33% | |
| -$1.84 | -$1.79 | +2.37% | |
| -$0.49 | N/A | +72.50% | |
| -$0.16 | N/A | +91.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $6.72M | $1.41M | -78.96% | |
| $4.12M | N/A | +191.62% | |
| $58.00M | N/A | +4,003.04% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -50.15% | ||
| -97.18% | ||
| +114.38% | ||
| -59.18% | ||
| +100.00% | ||
| +100.00% | ||
| +55.85% | ||
| +71.20% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.98 | ||
| $0.93 | ||
| $1.20 | ||
| $1.09 | ||
| $1.16 | ||
| -$0.08 | ||
| 1.09 | ||
| $0.20 | ||
| 38.28 | ||
| 165.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.41M | ||
| -$1.79 | ||
| $0.00 | ||
| 46.49% | ||
| -$67.06M | ||
| -4,744.37% | ||
| -$62.42M | ||
| -4,416.34% | ||
| -$66.94M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.94 | ||
| 0.38 | ||
| 0.31 | ||
| - | ||
| - | ||
| -45.23 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 548.45 | ||
| -6.30 | ||
| -3.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$32.19M | ||
| $8.08M | ||
| $18.58M | ||
| $17.39M | ||
| $50.77M | ||
| $45.81M | ||
| $30.19M | ||
| $30.01M | ||
| $10.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $63.84M | ||
| $67.00M | ||
| $1.47M | ||
| $8.48M | ||
| $117.10K | ||
| $0.00 | ||
| -$1.55M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$51.83M | ||
| $0.00 | ||
| $44.99M | ||
| $0.00 | ||
| -$51.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Ascendiant Capital | → | |
| BTIG | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → |
Analyst sentiment
Institutional ownership
Screeners with OTLK
FAQ
- What is the ticker symbol for Outlook Therapeutics, Inc.?
- The ticker symbol for Outlook Therapeutics, Inc. is NASDAQ:OTLK
- Does Outlook Therapeutics, Inc. pay dividends?
- No, Outlook Therapeutics, Inc. does not pay dividends
- What sector is Outlook Therapeutics, Inc. in?
- Outlook Therapeutics, Inc. is in the Healthcare sector
- What industry is Outlook Therapeutics, Inc. in?
- Outlook Therapeutics, Inc. is in the Biotechnology industry
- What country is Outlook Therapeutics, Inc. based in?
- Outlook Therapeutics, Inc. is headquartered in United States
- When did Outlook Therapeutics, Inc. go public?
- Outlook Therapeutics, Inc. initial public offering (IPO) was on June 14, 2016
- Is Outlook Therapeutics, Inc. in the S&P 500?
- No, Outlook Therapeutics, Inc. is not included in the S&P 500 index
- Is Outlook Therapeutics, Inc. in the NASDAQ 100?
- No, Outlook Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Outlook Therapeutics, Inc. in the Dow Jones?
- No, Outlook Therapeutics, Inc. is not included in the Dow Jones index
- When was Outlook Therapeutics, Inc. last earnings report?
- Outlook Therapeutics, Inc.'s most recent earnings report was on May 15, 2026
- When does Outlook Therapeutics, Inc. report earnings?
- The next expected earnings date for Outlook Therapeutics, Inc. is August 13, 2026
Data Sources & References
- OTLK Official Website www.outlooktherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649989/000110465925123264/0001104659-25-123264-index.htm
- OTLK Profile on Yahoo Finance finance.yahoo.com/quote/OTLK
- OTLK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/otlk